HCID 86740397、化合物 → HCID 86740401、化合物
反応式
ClCC([NH:5][C:6]1[S:7][CH:8]=[C:9]([C:11](=[N:34][O:35][CH3:36])[C:12]([NH:14][C@H:15]2[C@@H:18]([O:19][C:20](=[O:28])[CH2:21][C:22]3[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=3)[N:17]([S:29]([O-:32])(=[O:31])=[O:30])[C:16]2=[O:33])=[O:13])[N:10]=1)=O.[Na+:37].CSC(=S)N.[Na]>O>[NH2:5][C:6]1[S:7][CH:8]=[C:9]([C:11](=[N:34][O:35][CH3:36])[C:12]([NH:14][C@H:15]2[C@@H:18]([O:19][C:20](=[O:28])[CH2:21][C:22]3[CH:23]=[CH:24][CH:25]=[CH:26][CH:27]=3)[N:17]([S:29]([O-:32])(=[O:30])=[O:31])[C:16]2=[O:33])=[O:13])[N:10]=1.[Na+:37]参加物
4
実験手順
To a solution of 0.10 g of sodium (3S,4R)-3-[2-(2-chloroacetamidothiazol-4-yl)-2-methoxyiminoacetamido]-4-phenylacetoxy-2-oxoazetidine-1-sulfonate in 7 ml of water is added under ice-cooling 0.027 g of sodium monomethyldithiocarbamate, and the mixture is stirred at room temperature for 1.5 hours. Insolubles are filtered off, and the filtrate is purified on an XAD-II column to yield 0.044 g of sodium (3S,4R)-3-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-4-phenylacetoxy-2-oxoazetidine-1-sulfonate.
後処理
- filtrationInsolubles are filtered off
- customthe filtrate is purified on an XAD-II column
出典と根拠
- ORDレコード
- ord-e56fd8a700ab4a31b27543d518d9113f
- 出典データセット
- uspto-grants-1989_04
- 特許番号
- US04822788
反応ノート
読み込み中…